Resilience

Resilience

Broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$50.0m

Series A

$800m

Series B
*
N/A

$600m

Series C
*
N/A

$625m

Series D
*

N/A

Growth Equity VC
*

$410m

Debt
Total Funding$2.1b

Recent News about Resilience

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Resilience

Edit
Ology Bioservices
ACQUISITION by Resilience Apr 2021
Swiftscale Biologics
ACQUISITION by Resilience Dec 2021